Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2015

Open Access 01-12-2015 | Study protocol

Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial

Authors: Maguy Saffouh El Hajj, Nadir Kheir, Ahmad Mohd Al Mulla, Daoud Al-Badriyeh, Ahmad Al Kaddour, Ziyad R Mahfoud, Mohammad Salehi, Nadia Fanous

Published in: Trials | Issue 1/2015

Login to get access

Abstract

Background

It had been reported that up to 37% of the adult male population smokes cigarettes in Qatar. The Global Youth Tobacco Survey also stated that 13.4% of male school students aged 13 to 15 years in Qatar smoke cigarettes. Smoking cessation is key to reducing smoking-related diseases and deaths. Healthcare providers are in an ideal position to encourage smoking cessation. Pharmacists are the most accessible healthcare providers and are uniquely situated to initiate behavior change among patients. Many studies have shown that pharmacists can be successful in helping patients quit smoking. Studies demonstrating the effectiveness of pharmacist-delivered smoking cessation programs are lacking in Qatar. This proposal aims to test the effect of a structured smoking cessation program delivered by trained ambulatory pharmacists in Qatar.

Methods/Design

A prospective, randomized, controlled trial is conducted at eight ambulatory pharmacies in Qatar. Participants are randomly assigned to receive an at least four-session face-to-face structured patient-specific smoking cessation program conducted by the pharmacist or 5 to 10 min of unstructured brief smoking cessation advice (emulating current practice) given by the pharmacist. Both groups are offered nicotine replacement therapy if feasible. The primary outcome of smoking cessation will be confirmed by an exhaled carbon monoxide test at 12 months. Secondary outcomes constitute quality-of-life adjustment as well as cost analysis of program resources consumed, including per case and patient outcome.

Discussion

If proven to be effective, this smoking cessation program will be considered as a model that Qatar and the region can apply to decrease the smoking burden.

Trial registration

Clinical Trials NCT02123329.
Literature
1.
2.
3.
4.
5.
6.
Roth MT, Andrus MR, Westman EC. Outcomes from an outpatient smoking cessation clinic. Pharmacotherapy. 2005;25(2):279–88.CrossRefPubMed
7.
8.
9.
Hudmon KS, Prokhorov AV, Corelli RS. Tobacco cessation counseling: pharmacists’ opinions and practices. Patient Educ Couns. 2006;61:152–60.CrossRefPubMed
10.
Aquilino ML, Farris KB, Zillich AJ, Lowe JB. Smoking-cessation services in Iowa community pharmacies. Pharmacotherapy. 2003;23(5):666–73.CrossRefPubMed
11.
Sinclair HK, Bond CM, Stead LF. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev. 2004, Issue 1. Art. No.: CD003698. doi: 10.1002/14651858.CD003698.pub2.
12.
Maguire TA, McElnay JC, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction. 2001;96(2):325–31.CrossRefPubMed
13.
Vial RJ, Jones TE, Ruffin RE, Gilbert AL. Smoking cessation program using nicotine patches: linking hospital to the community. J Pharm Pract Res. 2002;32:57–62.CrossRef
14.
Carroll P, Rois R, Sarson D, Flynn J. A community pharmacy based smoking cessation program using transdermal nicotine replacement therapy: actions and outcomes. Aust Pharmacist. 2000;19:51–5.
15.
Sinclair HK, Bond CM, Lennox AS, Silcock J, Winfield AJ, Donnan PT. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomized controlled trial in Scotland. Tob Control. 1998;7:253–61.CrossRefPubMedPubMedCentral
16.
Zillich AJ, Ryan M, Adams A, Yeager B, Farris K. Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life. Pharmacotherapy. 2002;22:759–65.CrossRefPubMed
17.
Dent LA, Harris KJ, Noonan CW. Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother. 2009;43(2):194–201.PubMed
18.
Smith MD, McGhan WF, Lauger G. Pharmacist counseling and outcomes of smoking cessation. Am Pharm. 1995;NS35(8):20–9.CrossRefPubMed
19.
Kennedy DT, Giles JT, Chang ZG, Small RE, Edwards JH. Results of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc (Wash). 2002;42:51–6.CrossRef
20.
Dent LA, Scott JG, Lewis E. Pharmacist-managed tobacco cessation program in Veterans Health Administration community-based outpatient clinic. J Am Pharm Assoc (Wash DC). 2004;44:700–15.CrossRef
21.
Crealey GE, McElnay JC, Maguire TA, O’Neill C. Costs and effects associated with a community pharmacy-based smoking-cessation programme. Pharmacoeconomics. 1998;14(3):323–33.CrossRefPubMed
22.
McGhan WF, Smith MD. Pharmacoeconomic analysis of smoking cessation interventions. Am J Health Syst Pharm. 1996;53(1):45–52.PubMed
23.
Sinclair HK, Silcock J, Bond CM, Lennox AS, Winfield AJ. The cost-effectiveness of intensive pharmaceutical intervention in assisting people to stop smoking. Int J Pharm Pract. 1999;7:107–12.CrossRef
24.
Tran MT, Holdford DA, Kennedy DT, Small RE. Modeling the cost-effectiveness of a smoking cessation program in a community pharmacy practice. Pharmacotherapy. 2002;22(2):1623–31.CrossRefPubMed
25.
26.
27.
2008 PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care. 2008;53(9):1217–22.
28.
Hudmon KS, Corelli RL. ASHP therapeutic position statement on the cessation of tobacco Use. Am J Health Syst Pharm. 2009;66:291–307.CrossRef
29.
Al-Kuwari MG. Tobacco control in Qatar. Middle East J Fam Med. 2008;6(6):11–3.
30.
Al-Mulla A, Bener A. Cigarette smoking habits among Qatari population. Public Health Med. 2003;4(3):41–4.
31.
32.
Bener A, Zirie M, Kim EJ, Buz R, Zaza M, Nufal, et al. Measuring burden of diseases in a rapidly developing economy: state of Qatar. Glob J Health Sci. 2013;5(2):134–44.
33.
Ibrahim WH, Rasul KI, Khinji A, Ahmed MS, Bener A. Clinical and epidemiological characteristics of lung cancer cases in Qatar. East Mediterr Health J. 2010;16(2):166–70.PubMed
34.
35.
36.
37.
38.
Kennedy DT, Small RE. Development and implementation of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc. 2002;42(1):83–92.CrossRef
39.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict. 1991;86(9):1119–27.CrossRefPubMed
40.
Al Mohamed HI, Amin TT. Pattern and prevalence of smoking among students at King Faisal University, Al Hassa, Saudi Arabia. EMHJ. 2010;16(1):56–64.
41.
Asfar MD, Vander MW, Maziak W, Hammal F, Eissenberg T, Ward KD. Outcomes and adherence in Syria’s first smoking cessation trial. Am J Health Behav. 2008;32(2):146–56.CrossRefPubMed
42.
Olufade AO, Shaw JW, Foster SA, Leischow SJ, Hays RD, Coons SJ. Development of the smoking cessation quality of life questionnaire. Clin Ther. 1999;21(12):2113–30.CrossRefPubMed
43.
44.
Hudmon KS, Berger BA. Pharmacy applications of the transtheoretical model in smoking cessation. Am J Health Syst Pharm. 1995;52:282–7.PubMed
45.
46.
47.
Jatlow P, Toll BA, Leary V, Krishnan-Sarin S, O’Malley SS. Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence. Drug Alcohol Depend. 2008;98(3):203–9.CrossRefPubMedPubMedCentral
48.
Borelli B, Hogan J, Bock B, Pinto B, Roberts M, Marcus B. Predictors of quitting and dropout among women in a clinic-based smoking cessation program. Psychol Addict Behav. 2002;16(1):22–7.CrossRef
49.
50.
Kheir N, Zaidan M, Younes H, El Hajj M, Wilbur K, Jewesson PJ. Pharmacy education and practice in 13 Middle Eastern countries. Am J Pharm Educ. 2008;72(6):1–13.CrossRef
Metadata
Title
Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial
Authors
Maguy Saffouh El Hajj
Nadir Kheir
Ahmad Mohd Al Mulla
Daoud Al-Badriyeh
Ahmad Al Kaddour
Ziyad R Mahfoud
Mohammad Salehi
Nadia Fanous
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Trials / Issue 1/2015
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-015-0570-z

Other articles of this Issue 1/2015

Trials 1/2015 Go to the issue

Study protocol

Oropharyngeal administration of mother’s colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial

Research

Quality of randomized controlled trials reporting in the treatment of melasma conducted in China

Research

The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial: an adaptive trial design case study

Study protocol

Evaluation of a hospital-based day-structuring exercise programme on exacerbated behavioural and psychological symptoms in dementia - the exercise carrousel: study protocol for a randomised controlled trial

Study protocol

Clinical and cost effectiveness of computer treatment for aphasia post stroke (Big CACTUS): study protocol for a randomised controlled trial

Study protocol

PREVENTT: preoperative intravenous iron to treat anaemia in major surgery: study protocol for a randomised controlled trial